Literature DB >> 32296918

Characterization of Gut Microbiota in Hospitalized Patients with Clostridioides difficile Infection.

Bahareh Vakili1, Abolfazl Fateh2,3, Hamid Asadzadeh Aghdaei4, Fattah Sotoodehnejadnematalahi1, Seyed Davar Siadat5,6.   

Abstract

Clostridioides difficile infection (CDI) is one of the most common causes of nosocomial diarrhea in developed countries and the main cause in healthcare settings. This case-control study was designed to evaluate the composition of the gut microbiota dominant bacterial groups in patients with CDI compared to the healthy control subjects. A total of 100 adult subjects involving 50 inpatients with CDI and 50 healthy persons were enrolled in the study. C. difficile isolates were characterized according to the anaerobic culture and presence of toxin genes with multiplex PCR. An ecological analysis was performed real-time quantitative PCR for bacterial elements. The abundances of Enterococcus spp., Lactobacillus spp., Escherichia coli, C. difficile, and Akkermansia muciniphila were higher in group CDI compared with group HC (P < 0.05). The abundances of Bacteroides spp., Bifidobacterium spp., and Faecalibacterium prausnitzii were lower in group CDI than in group HC (P < 0.05). No significant difference was observed in the copy number of Prevotella genus between the CDI and HC subjects (P-value = 0.087). We observed that economic status and income levels were reduced at patients with CDI, however, there was no significant difference between CDI and HC group results and other variables, such as age, BMI, and educational level. These findings showed a reduction in butyrate-producing bacteria and increase in lactic acid-producing bacteria was seen in CDI status. Overrepresentation of Akkermansia may be a predictive marker for the development of nosocomial diarrhea can result in a worse CDI prognosis.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32296918     DOI: 10.1007/s00284-020-01980-x

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  21 in total

1.  Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota.

Authors:  Mary C Rea; Orla O'Sullivan; Fergus Shanahan; Paul W O'Toole; Catherine Stanton; R Paul Ross; Colin Hill
Journal:  J Clin Microbiol       Date:  2011-12-07       Impact factor: 5.948

Review 2.  The role of gut microbiota in Clostridium difficile infection.

Authors:  Michael Samarkos; Elpida Mastrogianni; Olga Kampouropoulou
Journal:  Eur J Intern Med       Date:  2018-02-07       Impact factor: 4.487

3.  Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study.

Authors:  Christian Milani; Andrea Ticinesi; Jacoline Gerritsen; Antonio Nouvenne; Gabriele Andrea Lugli; Leonardo Mancabelli; Francesca Turroni; Sabrina Duranti; Marta Mangifesta; Alice Viappiani; Chiara Ferrario; Marcello Maggio; Fulvio Lauretani; Willem De Vos; Douwe van Sinderen; Tiziana Meschi; Marco Ventura
Journal:  Sci Rep       Date:  2016-05-11       Impact factor: 4.379

4.  Gut bacterial communities of diarrheic patients with indications of Clostridioides difficile infection.

Authors:  Dominik Schneider; Andrea Thürmer; Kathleen Gollnow; Raimond Lugert; Katrin Gunka; Uwe Groß; Rolf Daniel
Journal:  Sci Data       Date:  2017-10-17       Impact factor: 6.444

5.  Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load.

Authors:  Sung-Hee Han; Joowon Yi; Ji-Hoon Kim; SangWon Lee; Hee-Won Moon
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

6.  Clostridium difficile isolated from faecal samples in patients with ulcerative colitis.

Authors:  Parisa Shoaei; Hasan Shojaei; Mohammad Jalali; Farzin Khorvash; Sayed Mohsen Hosseini; Behrooz Ataei; Bahareh Vakili; Fatemeh Ebrahimi; Hossein Tavakoli; Zahra Esfandiari; J Scott Weese
Journal:  BMC Infect Dis       Date:  2019-04-30       Impact factor: 3.090

7.  Molecular epidemiology of Clostridium difficile infection in Iranian hospitals.

Authors:  Parisa Shoaei; Hasan Shojaei; Farzin Khorvash; Sayed Mohsen Hosseini; Behrooz Ataei; Hossein Tavakoli; Mohammad Jalali; J Scott Weese
Journal:  Antimicrob Resist Infect Control       Date:  2019-01-14       Impact factor: 4.887

8.  Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea.

Authors:  Marta Hernández; Mónica de Frutos; David Rodríguez-Lázaro; Luis López-Urrutia; Narciso M Quijada; Jose María Eiros
Journal:  Front Microbiol       Date:  2019-01-14       Impact factor: 5.640

9.  Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes.

Authors:  Jure Skraban; Saso Dzeroski; Bernard Zenko; Domen Mongus; Simon Gangl; Maja Rupnik
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

10.  Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.

Authors:  William Sangster; John P Hegarty; Kathleen M Schieffer; Justin R Wright; Jada Hackman; David R Toole; Regina Lamendella; David B Stewart
Journal:  Front Microbiol       Date:  2016-05-25       Impact factor: 5.640

View more
  8 in total

1.  Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection.

Authors:  Bahareh Vakili; Abolfazl Fateh; Hamid Asadzadeh Aghdaei; Fattah Sotoodehnejadnematalahi; Seyed Davar Siadat
Journal:  Infect Drug Resist       Date:  2020-08-05       Impact factor: 4.003

Review 2.  Disease-associated dysbiosis and potential therapeutic role of Akkermansia muciniphila, a mucus degrading bacteria of gut microbiome.

Authors:  Vidushi Aggarwal; Sushant Sunder; Smita Rastogi Verma
Journal:  Folia Microbiol (Praha)       Date:  2022-05-20       Impact factor: 2.629

Review 3.  Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults.

Authors:  Iulia-Magdalena Vasilescu; Mariana-Carmen Chifiriuc; Gratiela Gradisteanu Pircalabioru; Roxana Filip; Alexandra Bolocan; Veronica Lazăr; Lia-Mara Diţu; Coralia Bleotu
Journal:  Front Microbiol       Date:  2022-01-20       Impact factor: 5.640

Review 4.  Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection.

Authors:  Elisa Martinez; Bernard Taminiau; Cristina Rodriguez; Georges Daube
Journal:  Pathogens       Date:  2022-07-08

5.  Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense.

Authors:  Katherine A Dunn; Tamara MacDonald; Gloria J Rodrigues; Zara Forbrigger; Joseph P Bielawski; Morgan G I Langille; Johan Van Limbergen; Ketan Kulkarni
Journal:  Front Cell Infect Microbiol       Date:  2022-07-27       Impact factor: 6.073

Review 6.  Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges.

Authors:  Yuheng Luo; Cong Lan; Hua Li; Qingyuan Ouyang; Fanli Kong; Aimin Wu; Zhihua Ren; Gang Tian; Jingyi Cai; Bing Yu; Jun He; André-Denis G Wright
Journal:  NPJ Biofilms Microbiomes       Date:  2022-10-17       Impact factor: 8.462

7.  Probiotic Yeasts and Vibrio anguillarum Infection Modify the Microbiome of Zebrafish Larvae.

Authors:  Orlando Vargas; María Soledad Gutiérrez; Mario Caruffo; Benjamín Valderrama; Daniel A Medina; Katherine García; Angélica Reyes-Jara; Magaly Toro; Carmen G Feijóo; Paola Navarrete
Journal:  Front Microbiol       Date:  2021-06-23       Impact factor: 5.640

8.  An Osmotic Laxative Renders Mice Susceptible to Prolonged Clostridioides difficile Colonization and Hinders Clearance.

Authors:  Sarah Tomkovich; Ana Taylor; Jacob King; Joanna Colovas; Lucas Bishop; Kathryn McBride; Sonya Royzenblat; Nicholas A Lesniak; Ingrid L Bergin; Patrick D Schloss
Journal:  mSphere       Date:  2021-09-29       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.